Medications

Soaring generic drug prices draw Senate scrutiny

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

Nov 20, 2014
popularity 4 / 5 (2) | comments 0

Health care M&A leads global deal surge

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and ...

Nov 23, 2014
popularity 5 / 5 (1) | comments 0
  • Pages: 1